Fidaxomicin vs Vancomycin for the Treatment of a First Episode of Clostridium Difficile Infection: A Meta-analysis and Systematic Review

Clostridium difficile infection (CDI) continues to possess a significant disease burden in the United States (US) as well as all over the world. Given the increase in severity and recurrence rate, the decrease in cure rate, and the fact that the virulent ribotype 027 strain remains one of the most c...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Momani, Laith A, Abughanimeh, Omar, Boonpheng, Boonphiphop, Gabriel, Joseph Gabriel, Young, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089486/
https://www.ncbi.nlm.nih.gov/pubmed/30112254
http://dx.doi.org/10.7759/cureus.2778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089486/
https://www.ncbi.nlm.nih.gov/pubmed/30112254
http://dx.doi.org/10.7759/cureus.2778

Ejemplares similares